Centrally-administered opioid selective agonists inhibit drinking in the rat

Robert L. Spencer, David Deupree, Sigmund Hsiao, Henry I. Mosberg, Victor J Hruby, Thomas F. Burks, Frank Porreca

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The effects of intracerebroventricular injection of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, and U50,488H), and delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake of 14 hr water deprived rats was studied. All agonists caused a dose related decrease in time spent drinking, with a rank order potency of dynorphin-(1-13) > morphine > ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception of morphine, all of the compounds increased the latency to begin drinking, but only at the highest doses tested. The rank order potency for this endpoint was dynorphin-(1-13) = ethylketocyclazocine > [D-Pen2,D-Pen5]enkephalin > U503, 488H. The potent inhibition of drinking following centrally-given dynorphin-(1-13), at doses that did not affect the latency to begin drinking, supports a role for endogenous dynorphin in the homeostatic control of water balance. This function may not be primarily mediated through activation of a kappa opioid receptor since dynorphin-(1-13) was 80-230 times more potent than the selective kappa agonist, U50,488H or ethylketocyclazocine.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalPharmacology, Biochemistry and Behavior
Volume25
Issue number1
DOIs
StatePublished - 1986

Fingerprint

Ethylketocyclazocine
Opioid Analgesics
Drinking
D-Penicillamine (2,5)-Enkephalin
Rats
Morphine
Water
Dynorphins
kappa Opioid Receptor
Chemical activation
dynorphin (1-13)
Injections

Keywords

  • Drinking
  • Dynorphin
  • Opioids
  • Water balance

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Centrally-administered opioid selective agonists inhibit drinking in the rat. / Spencer, Robert L.; Deupree, David; Hsiao, Sigmund; Mosberg, Henry I.; Hruby, Victor J; Burks, Thomas F.; Porreca, Frank.

In: Pharmacology, Biochemistry and Behavior, Vol. 25, No. 1, 1986, p. 77-82.

Research output: Contribution to journalArticle

Spencer, Robert L. ; Deupree, David ; Hsiao, Sigmund ; Mosberg, Henry I. ; Hruby, Victor J ; Burks, Thomas F. ; Porreca, Frank. / Centrally-administered opioid selective agonists inhibit drinking in the rat. In: Pharmacology, Biochemistry and Behavior. 1986 ; Vol. 25, No. 1. pp. 77-82.
@article{cb931eb0c2194ced81dce1568d9cea8b,
title = "Centrally-administered opioid selective agonists inhibit drinking in the rat",
abstract = "The effects of intracerebroventricular injection of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, and U50,488H), and delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake of 14 hr water deprived rats was studied. All agonists caused a dose related decrease in time spent drinking, with a rank order potency of dynorphin-(1-13) > morphine > ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception of morphine, all of the compounds increased the latency to begin drinking, but only at the highest doses tested. The rank order potency for this endpoint was dynorphin-(1-13) = ethylketocyclazocine > [D-Pen2,D-Pen5]enkephalin > U503, 488H. The potent inhibition of drinking following centrally-given dynorphin-(1-13), at doses that did not affect the latency to begin drinking, supports a role for endogenous dynorphin in the homeostatic control of water balance. This function may not be primarily mediated through activation of a kappa opioid receptor since dynorphin-(1-13) was 80-230 times more potent than the selective kappa agonist, U50,488H or ethylketocyclazocine.",
keywords = "Drinking, Dynorphin, Opioids, Water balance",
author = "Spencer, {Robert L.} and David Deupree and Sigmund Hsiao and Mosberg, {Henry I.} and Hruby, {Victor J} and Burks, {Thomas F.} and Frank Porreca",
year = "1986",
doi = "10.1016/0091-3057(86)90233-9",
language = "English (US)",
volume = "25",
pages = "77--82",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Centrally-administered opioid selective agonists inhibit drinking in the rat

AU - Spencer, Robert L.

AU - Deupree, David

AU - Hsiao, Sigmund

AU - Mosberg, Henry I.

AU - Hruby, Victor J

AU - Burks, Thomas F.

AU - Porreca, Frank

PY - 1986

Y1 - 1986

N2 - The effects of intracerebroventricular injection of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, and U50,488H), and delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake of 14 hr water deprived rats was studied. All agonists caused a dose related decrease in time spent drinking, with a rank order potency of dynorphin-(1-13) > morphine > ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception of morphine, all of the compounds increased the latency to begin drinking, but only at the highest doses tested. The rank order potency for this endpoint was dynorphin-(1-13) = ethylketocyclazocine > [D-Pen2,D-Pen5]enkephalin > U503, 488H. The potent inhibition of drinking following centrally-given dynorphin-(1-13), at doses that did not affect the latency to begin drinking, supports a role for endogenous dynorphin in the homeostatic control of water balance. This function may not be primarily mediated through activation of a kappa opioid receptor since dynorphin-(1-13) was 80-230 times more potent than the selective kappa agonist, U50,488H or ethylketocyclazocine.

AB - The effects of intracerebroventricular injection of mu (morphine), kappa (dynorphin-(1-13), ethylketocyclazocine, and U50,488H), and delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake of 14 hr water deprived rats was studied. All agonists caused a dose related decrease in time spent drinking, with a rank order potency of dynorphin-(1-13) > morphine > ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception of morphine, all of the compounds increased the latency to begin drinking, but only at the highest doses tested. The rank order potency for this endpoint was dynorphin-(1-13) = ethylketocyclazocine > [D-Pen2,D-Pen5]enkephalin > U503, 488H. The potent inhibition of drinking following centrally-given dynorphin-(1-13), at doses that did not affect the latency to begin drinking, supports a role for endogenous dynorphin in the homeostatic control of water balance. This function may not be primarily mediated through activation of a kappa opioid receptor since dynorphin-(1-13) was 80-230 times more potent than the selective kappa agonist, U50,488H or ethylketocyclazocine.

KW - Drinking

KW - Dynorphin

KW - Opioids

KW - Water balance

UR - http://www.scopus.com/inward/record.url?scp=0022545144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022545144&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(86)90233-9

DO - 10.1016/0091-3057(86)90233-9

M3 - Article

C2 - 2875475

AN - SCOPUS:0022545144

VL - 25

SP - 77

EP - 82

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 1

ER -